NEW YORK, May 2 (GenomeWeb News) - European regulators have granted CE Mark approval to Jurilab and Nanogen's DrugMet drug-metabolizing enzyme microarray, the companies said today.

 

The firms can now sell the product in the European Union for clinical use as an in vitro diagnostic.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.